STEPHAN DIETRICH A (President and CEO) purchased 11.3% of their position (1.27K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.9K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/10/2020ACC: 0001104659-20-071857
DirectorOfficer· President and CEO
Since Jul 2019
+1.27K
Net shares
Net buyer
$9.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.27K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.27K
Price / share
$7.73
Trade value
$9.86K
% of position
11.3%
6/9/2020
11.25K→12.53K
Total
Net shares
+1.27K
Net value
$9.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2020 | P · Purchase | +1.27K | $7.73 | $9.86K | 11.3% | 11.25K | 12.53K |
| Total | +1.27K | $9.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.55M
Total
2.55M indirect2.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.55M | Indirect |
| Total | 2.55M | 2.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported